BMPR2 and pulmonary arterial hypertension: Herein, leniolisib effectively blocked AKT activation in BMPR2-silenced PAECs and partially normalized cell proliferation, EndoMT and apoptosis resistance, phenotypic features associated with end stage vascular remodeling in PAH.